Details for New Drug Application (NDA): 212927
The generic ingredient in TIOCYSTIN is tiopronin. There is one drug master file entry for this compound. Eight suppliers are listed for this compound. Additional details are available on the tiopronin profile page.
Summary for 212927
| Tradename: | TIOCYSTIN |
| Applicant: | Casper Pharma Llc |
| Ingredient: | tiopronin |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 100MG | ||||
| Approval Date: | Jun 2, 2026 | TE: | RLD: | Yes | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 200MG | ||||
| Approval Date: | Jun 2, 2026 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
